FEATURE ARTICLES
This Q&A discusses best practices for integrating program managers into a sponsor company and how program managers help bridge the gaps between various stakeholders.
- 3 [Potential] Solutions To A More Resilient Supply Chain
- September 2025 — CDMO Opportunities And Threats Report
- Extreme Weather Is Testing Pharma's Resilience — Is It Ready?
- Risk-Based Analytical Method Selection In Cleaning Validation Using ASTM International Standards
- Eco-Friendly HBL: Cheaper, Cleaner, And Ready For Pharma
- Import Product Specifications And Drug Registration Testing For China
- Trust But Verify: Validating AI In Pharma's GxP World
PHARMA ONLINE WHITE PAPERS
-
![GettyImages-2190502074-water-filtration-laboratory]( "Innovation In Filtration")
Innovation In FiltrationFiltration removes contaminants to ensure safety and is essential in various applications, from lab-scale tasks to GMP production. Explore how its simplicity and reliability make it indispensable.
-
The Evolution Of Antibody-Drug Manufacturing6/3/2024
Explore how ADC chemistry and manufacturing have evolved, the challenges this dynamic growth has created, and how CDMOs are adapting to these changes to meet customer needs, now and in the future.
-
Next Generation Sequencing In Viral Safety Testing7/25/2025
Next Generation Sequencing (NGS) offers a sensitive, high-throughput solution for detecting adventitious viral agents (AVAs), improving biopharmaceutical safety and accelerating regulatory-compliant product development.
-
A Toolbox For An Effective Tech Transfer7/23/2025
As drug development costs rise, companies are embracing digital-first strategies and Pharma 4.0 principles to streamline operations, enhance tech transfer, and accelerate time-to-market through innovation.
-
White Paper: Characterization Of Spray Dried Biologics5/7/2025
Discover how spray drying can transform the formulation of complex biologics by improving stability, delivery, and functionality, with insights into the critical techniques and strategies needed for successful development.
-
Vial Fogging: Practical Considerations For Vial Selection10/16/2024
Vial fogging is a common phenomenon observed in lyophilized biologic drug products. This document presents two case studies that explore critical factors contributing to vial fogging and inform vial selection decisions.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Improve Productivity And Reduce Risk With Biostat® RM
- Seed Train Intensification Using High Cell Density Cryopreservation
- Bioanalytical Quantification Of A Biotherapeutic Peptide
- Site Transfer Of Tablet Production From Ex-U.S. To Georgia Site
- Development Of Separation Methods For GLP-1 Synthetic Peptides
NEWSLETTER ARCHIVE
- 10.24.25 -- Compact Solutions, Scalable Systems, And Smart Instruments Driving Efficiency From Lab To Production
- 10.23.25 -- Compliance To Competitive Advantage: EAM/CMMS Insights
- 10.23.25 -- Building The Biopharma Manufacturing Facility Of The Future Requires A Phased IT/OT Strategy
- 10.23.25 -- STREAM Edition: Solid Phase Versus Liquid Phase Peptide Synthesis
- 10.22.25 -- Your Tablet Production Blueprint Is Here
INDUSTRY NEWS
-
![business peope negotiating-GettyImages-637902194]( "9 Drugs Granted Fast Track By FDA's Voucher Program")
9 Drugs Granted Fast Track By FDA's Voucher ProgramWith targets like pancreatic cancer, deafness, blindness, infertility and vaping addiction, these drugs were chosen due to an unmet need, addressing a public health crisis, boosting domestic manufacturing or increasing affordability.
-
![Pharmaceutical sorting machine, pills-GettyImages-1499814881]( "Leaders In The Excipient Market: Region And Type")
Leaders In The Excipient Market: Region And TypeThough North America led the market with a 38.32% market share of $3.15 billion in 2024, Asia Pacific is expected to have the fastest growth in the upcoming years.
-
![GettyImages-2189405678-GLP-1-obesity]( "Pfizer Strengthens Obesity Foothold With Metsera Acquisition")
Pfizer Strengthens Obesity Foothold With Metsera AcquisitionAfter discouraging efforts to bring two oral obesity drugs to market—danuglipron and lotiglipron—this acquisition launches Pfizer back into the obesity therapeutic game.
-
![weight loss, diabetes, insulin pen-GettyImages-2196049931]( "FDA Cracks Down On GLP-1 Imports")
FDA Cracks Down On GLP-1 ImportsGLP-1 bulk drug substances must be detained without physical examination (DWPE) unless they are on a list (Green List) of approved foreign GLP-1 manufacturers.
-
![Dollar Icon from Medical pills-GettyImages-1708867150]( "Oregon Court Upholds Drug Price Transparency Law")
Oregon Court Upholds Drug Price Transparency LawThe law was first enacted in 2018, followed by a lawsuit by Pharmaceutical Research and Manufacturers of America (PhRMA) in 2019, claiming an infringement of free speech for pharmaceutical companies and violation of public property. PhRMA asked the court to bar Oregon from enforcing the law.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
Comecer To Present Advanced Fill/Finish Technologies At ISPE Annual Meeting10/24/2025
This year, we are putting the spotlight on our advanced fill-finish technologies, which are designed to address the evolving challenges of pharmaceutical manufacturing with precision, efficiency and reliability.
-
Aseptic Filling OEM AST To Exhibit At CPHI Frankfurt 202510/23/2025
From R&D and manufacturing to packaging and distribution, CPHI is where groundbreaking ideas meet the partnerships that bring them to life.
-
U.S. Peptide Manufacturing Capacity Expands As SK Pharmteco Invests In Rancho Cordova Site10/23/2025
SK pharmteco, a global contract development and manufacturing organization (CDMO), announced today a $6.1 million investment in its Rancho Cordova facility to expand and equip a new lab and CGMP-kilo-scale facility for Solid-Phase Peptide Synthesis (SPPS) and purification. This expansion, combined with SK pharmteco’s industry-leading chromatography expertise and existing development and manufacturing capabilities in the United States, positions the company to meet the rising demand for U.S. peptide development and domestic clinical and commercial manufacturing.
-
Upperton Expands High Precision Filling Capability At Nottingham Facility10/22/2025
The system has been installed at Upperton’s state-of-the-art 60,000-square-foot GMP facility. The site supports formulation development and clinical manufacturing across a broad range of dosage forms, including oral solids, nasal, pulmonary and parenteral.
-
Cambrex Unveils $120 Million Investment To Expand API Manufacturing And Strengthen U.S. Drug Supply Resilience10/22/2025
Cambrex, a leading global CDMO, is addressing increased demand for API development and manufacturing and accelerating the company’s leadership role in the fast-growing peptide therapeutics market.
